"Viral Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease.
| Descriptor ID |
D014765
|
| MeSH Number(s) |
D20.215.894.899
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Viral Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Viral Vaccines".
This graph shows the total number of publications written about "Viral Vaccines" by people in this website by year, and whether "Viral Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 1 | 8 |
| 1997 | 4 | 1 | 5 |
| 1998 | 7 | 2 | 9 |
| 1999 | 7 | 2 | 9 |
| 2000 | 5 | 1 | 6 |
| 2001 | 4 | 2 | 6 |
| 2002 | 8 | 2 | 10 |
| 2003 | 7 | 0 | 7 |
| 2004 | 6 | 4 | 10 |
| 2005 | 4 | 4 | 8 |
| 2006 | 5 | 0 | 5 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 1 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 4 | 1 | 5 |
| 2015 | 3 | 1 | 4 |
| 2016 | 3 | 2 | 5 |
| 2017 | 4 | 1 | 5 |
| 2018 | 1 | 2 | 3 |
| 2019 | 4 | 3 | 7 |
| 2020 | 14 | 2 | 16 |
| 2021 | 5 | 2 | 7 |
| 2022 | 10 | 1 | 11 |
| 2023 | 4 | 0 | 4 |
| 2024 | 2 | 3 | 5 |
| 2025 | 9 | 0 | 9 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Viral Vaccines" by people in Profiles.
-
A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults. J Infect Dis. 2026 Mar 17; 233(3):e641-e645.
-
Efficacy, safety, and immunogenicity of Lassa fever vaccines: A living systematic review and landscape analysis of vaccine candidates. PLoS One. 2025; 20(12):e0338128.
-
Community interpretation of a consent form and willingness to participate in a Nipah virus vaccine trial in Bangladesh. Vaccine. 2025 Dec 05; 68:127953.
-
Community willingness to participate in a Nipah vaccine trial in Bangladesh. Vaccine. 2025 Aug 30; 62:127578.
-
Marburg virus glycoprotein mRNA vaccine is more protective than a virus-like particle-forming mRNA vaccine. J Clin Invest. 2025 Sep 02; 135(17).
-
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses. Nat Commun. 2025 Jul 01; 16(1):5702.
-
Safety, immunogenicity, and effectiveness of chikungunya vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis. Reprod Health. 2025 Apr 18; 22(1):56.
-
Safety, immunogenicity, efficacy, and effectiveness of Lassa fever vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis. Reprod Health. 2025 Apr 15; 22(1):53.
-
Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines. Hum Vaccin Immunother. 2025 Dec; 21(1):2463191.
-
Norovirus replication, host interactions and vaccine advances. Nat Rev Microbiol. 2025 Jun; 23(6):385-401.